SENOTHERAPEUTIX
Houston, US · 1 known investors
Senotherapeutix (d/b/a Gerotherapeutix) develops gerotherapeutics based on its MitoXcel geropeptide platform, which targets mitochondrial mechanisms of cellular aging to improve healthspan and extend lifespan. The company operates three subsidiaries spanning longevity therapeutics (Eos Senolytix), oncology peptides (Perseus Senolytix), and controllable gene therapies (Phoenix Senolytix).
Founders & leadership
DS
Dr. SlawinFounder & Leader
Investors · 1
Frequently asked questions
- What does SENOTHERAPEUTIX do?
- Senotherapeutix (d/b/a Gerotherapeutix) develops gerotherapeutics based on its MitoXcel geropeptide platform, which targets mitochondrial mechanisms of cellular aging to improve healthspan and extend lifespan. The company operates three subsidiaries spanning longevity therapeutics (Eos Senolytix), oncology peptides (Perseus Senolytix), and controllable gene therapies (Phoenix Senolytix).
- Who founded SENOTHERAPEUTIX?
- SENOTHERAPEUTIX was founded by Dr. Slawin.
- Who are SENOTHERAPEUTIX's investors?
- SENOTHERAPEUTIX's investors include Rapha Capital Management, LLC.
- Where is SENOTHERAPEUTIX headquartered?
- SENOTHERAPEUTIX is headquartered in Houston, US.